C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/04 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) C07H 21/02 (2006.01) C07H 21/04 (2006.01) C07K 4/12 (2006.01) C07K 7/00 (2006.01) C07K 9/00 (2006.01) C07K 14/705 (2006.01)
Patent
CA 2392764
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare carcino-embryonic antigen (CEA) epitopes, and to develop epitope-based vaccines directed towards CEA-bearing tumors. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of cancer.
L'invention fait appel à nos connaissances des mécanismes par lesquels un antigène est reconnu par des lymphocytes T, pour identifier et préparer des épitopes de l'antigène carcinoembryonnaire (ACE) et pour mettre au point des vaccins sur la base de ces épitopes dirigés contre les tumeurs contenant des ACE. Plus précisément, cette demande concerne la découverte de compositions pharmaceutiques et leurs méthodes d'utilisation dans la prévention et le traitement du cancer.
Celis Esteban
Chesnut Robert
Fikes John
Keogh Elissa
Sette Alessandro
Epimmune Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Inducing cellular immune responses to carcinoembryonic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inducing cellular immune responses to carcinoembryonic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inducing cellular immune responses to carcinoembryonic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1630874